Scholarlink

<p>Sarcopenia, characterized by progressive age-related declines in skeletal muscle mass and function, is exacerbated by inadequate protein intake in elderly populations. This study aimed to evaluate the effects of fermented <i>Tenebrio molitor</i> with <i>Lactobacillus plantarum</i> as a sustainable protein supplement against dexamethasone-induced myotube atrophy in C2C12 myoblasts and muscle atrophy in a C57BL/6 mouse model. We evaluated the effect of <i>Tenebrio molitor</i> with <i>Lactobacillus plantarum</i> using various methods, including immunofluorescence staining, Western blot, quantitative polymerase chain reaction, exercise performance measurement, and muscle tissue analysis. The results showed that <i>Tenebrio molitor</i> with <i>Lactobacillus plantarum</i> treatment significantly improved myotube area, myotube diameter, expression of myogenin and myosin heavy chain in dexamethasone-induced C2C12 myotubes. In addition, <i>Tenebrio molitor</i> with <i>Lactobacillus plantarum</i> enhanced the expression of myogenic regulatory factors, such as myogenic factor 5 and myogenin and reduced the expression of protein degradation marker, including atrogin-1, muscle really interesting new gene finger protein-1, and myostatin in the myotubes. In dexamethasone-treated mice, <i>Tenebrio molitor</i> with <i>Lactobacillus plantarum</i> increased exercise capacity and muscle weight, while inhibiting myosin heavy chain and muscle atrophy markers’ expression. These findings highlight the potential of <i>Tenebrio molitor</i> with <i>Lactobacillus plantarum</i> as a sustainable protein source for managing sarcopenia by preserving muscle mass and improving physical function, suggesting it as a potential therapeutic agent for treating muscle weakness and atrophy in aging populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fermented Tenebrio molitor larvae extract with Lactobacillus plantarum ameliorates dexamethasone-induced muscle atrophy in vitro and in vivo

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月11日

查看全文
  • Su-Vin Kim,
  • Hyun Sol Jo,
  • Seok Jun Son,
  • Mi Jeong Sung,
  • Sun Mee Hong,
  • Sang-Hee Lee

摘要

Sarcopenia, characterized by progressive age-related declines in skeletal muscle mass and function, is exacerbated by inadequate protein intake in elderly populations. This study aimed to evaluate the effects of fermented Tenebrio molitor with Lactobacillus plantarum as a sustainable protein supplement against dexamethasone-induced myotube atrophy in C2C12 myoblasts and muscle atrophy in a C57BL/6 mouse model. We evaluated the effect of Tenebrio molitor with Lactobacillus plantarum using various methods, including immunofluorescence staining, Western blot, quantitative polymerase chain reaction, exercise performance measurement, and muscle tissue analysis. The results showed that Tenebrio molitor with Lactobacillus plantarum treatment significantly improved myotube area, myotube diameter, expression of myogenin and myosin heavy chain in dexamethasone-induced C2C12 myotubes. In addition, Tenebrio molitor with Lactobacillus plantarum enhanced the expression of myogenic regulatory factors, such as myogenic factor 5 and myogenin and reduced the expression of protein degradation marker, including atrogin-1, muscle really interesting new gene finger protein-1, and myostatin in the myotubes. In dexamethasone-treated mice, Tenebrio molitor with Lactobacillus plantarum increased exercise capacity and muscle weight, while inhibiting myosin heavy chain and muscle atrophy markers’ expression. These findings highlight the potential of Tenebrio molitor with Lactobacillus plantarum as a sustainable protein source for managing sarcopenia by preserving muscle mass and improving physical function, suggesting it as a potential therapeutic agent for treating muscle weakness and atrophy in aging populations.